MHAPT "Zarita Johanna" University Hospital
Sofia, 1431, Bulgaria
NCT Number: NCT00857480
A study in healthy volunteers to determine whether different drugs metabolised by the liver have any effects on how NRL972 is processed within the body.
Looking for future studies?
Notify Me21 year–40 year
All sexes
Interventional
Phase 1
Sofia, 1431, Bulgaria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
General - all subjects
General - all females
Single intravenous administration of 2 mg NRL972
Time frame: 4 hours post-dose
Time frame: 4 hours post-dose
Norgine
Industry
A Single-Centre, Open, Controlled, Randomised Cross-Over Study in Healthy Male and Female Volunteers to Evaluate the Pharmacokinetics of Cholyl-Lysyl-Fluorescein (NRL972) in the Presence of Medication-Induced Changes in Cytochrome P450 or Biliary Transporter Proteins. Part B: Interaction With Ursodeoxycholic Acid and Cloxacillin
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07069725
Digestive System Diseases, Fibrosis
Stockholm, Sweden
View Trial DetailsNCT06750276
Digestive System Diseases, Fibrosis
Chandler, Arizona, United States
View Trial DetailsNCT05904470
Blood-Borne Infections, Chronic Disease
San Antonio, Texas, United States
View Trial DetailsNCT02778425
Blood Platelet Disorders, Cytopenia
Jinan, Shandong, China
View Trial Details